Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × demcizumab × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fallopian Tube Neoplasms 1

Interventions

Carboplatin 145 Paclitaxel 133 Bevacizumab 73 Gemcitabine 41 Taxes 40 liposomal doxorubicin 36 Cisplatin 33 pembrolizumab 32 Topotecan 32 Cyclophosphamide 23 olaparib 22 Immunoglobulin G 21 Disulfides 21 Specimen Handling 19 Docetaxel 19 niraparib 17 Drug Therapy 17 Magnetic Resonance Spectroscopy 16 Biopsy 15 mirvetuximab soravtansine 14 Doxorubicin 14 Hyperthermic Intraperitoneal Chemotherapy 12 rucaparib 11 Nivolumab 11 Cytoreduction Surgical Procedures 10 Chemotherapy, Adjuvant 10 Albumin-Bound Paclitaxel 10 Platinum 9 130-nm albumin-bound paclitaxel 9 veliparib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01952249 2020-09-09

SIERRA

Mereo BioPharma

Phase 1 Terminated

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡